3,813
Views
11
CrossRef citations to date
0
Altmetric
Articles

(De-)assetizing pharmaceutical patents: Patent contestations behind a blockbuster drug

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Théo Bourgeron & Susi Geiger. (2022) Building the weak hand of the state: tracing the market boundaries of high pharmaceutical prices in France. New Political Economy 27:5, pages 837-850.
Read now
Susi Geiger & Nicole Gross. (2022) Leaning in or falling over? Epistemological liminality and the knowledges that make a market. Journal of Cultural Economy 0:0, pages 1-14.
Read now

Articles from other publishers (7)

Susi Geiger & Nicole Gross. (2023) Tech sharing, not tech hoarding: Covid-19, global solidarity, and the failed responsibility of the pharmaceutical industry. Organization 31:3, pages 567-582.
Crossref
Valbona Muzaka. (2023) The knowledge-leveraging corporation in the neoliberalisation-financialisation nexus. Competition & Change 28:2, pages 274-292.
Crossref
Toni Prug & Mislav Žitko. (2023) Social Forms Beyond Value: Public Wealth and Its Contradictions. Critical Sociology.
Crossref
Shuo-Min Lee, Jen-Shyang Chen, Chien-Lin Hsu & Chi-Cheng Chang. (2023) A Business Strategy Framework for Patent Pooling in the Solar Cell Supply Chain. Sustainability 15:21, pages 15573.
Crossref
Susi Geiger & Théo Bourgeron. (2023) In the Name of Transparency: Organizing European pharmaceutical markets through struggles over transparency devices. Organization Studies 44:11, pages 1751-1773.
Crossref
Nicole Gross & Susi Geiger. (2023) Choreographing for public value in digital health?. Big Data & Society 10:2.
Crossref
Sarah Wadmann. (2023) Disease classification: A framework for analysis of contemporary developments in precision medicine. SSM - Qualitative Research in Health 3, pages 100217.
Crossref